Valuation: Arvee Laboratories (India) Ltd.

Market Cap 1.48B 15.49M 13.54M 12.45M 11.6M 22.01M 22.34M 149M 58.09M 725M 58.15M 56.91M 2.5B P/E 2024
151x
P/E 2025 72.9x
Enterprise Value 1.44B 15.09M 13.19M 12.12M 11.3M 21.43M 21.75M 146M 56.56M 706M 56.63M 55.41M 2.43B EV / Sales 2024
5.18x
EV / Sales 2025 3.96x
Free-Float
99%
Yield 2024 *
-
Yield 2025 -
1 day+1.41%
1 week-0.05%
Current month-0.36%
1 month+4.00%
3 months+19.56%
6 months-17.49%
Current year-22.67%
1 week 160
Extreme 160
179
1 month 157
Extreme 157
189.89
Current year 129.11
Extreme 129.11
208
1 year 129.11
Extreme 129.11
290.78
3 years 103.6
Extreme 103.6
315
5 years 62.9
Extreme 62.9
315
10 years 18.8
Extreme 18.8
315
Manager TitleAgeSince
Chief Executive Officer 52 2014-03-31
Director of Finance/CFO 42 2018-05-09
Compliance Officer 35 2019-02-14
Director TitleAgeSince
Director/Board Member 38 2021-09-30
Chairman 52 2014-03-31
Director/Board Member 42 2025-08-11
Change 5-day change 1-year change 3-year change Capi.($)
+1.41%-0.05%-16.77%+39.21% 19.09M
-0.94%+1.80%+44.30%+40.17% 80.23B
+0.29%+0.04%+13.22%+6.81% 47.11B
-0.46%+0.06%+2.62%+24.29% 17.08B
+3.67%+3.07%+75.84%+86.77% 15.55B
+2.97%+6.26%+48.65%+31.80% 9.8B
-10.00%+18.86%+303.76%+146.21% 8.4B
+0.83%+3.73%-1.33%-20.15% 9.28B
-0.19%+2.26%-13.59%+22.83% 8.7B
+1.22%-0.75%-3.66% - 7.73B
Average -0.12%+2.45%+45.30%+41.99% 20.39B
Weighted average by Cap. -0.25%+1.83%+40.56%+34.97%

Financials

2024 2025
Net sales 303M 3.19M 2.79M 2.56M 2.39M 4.53M 4.6M 30.74M 11.95M 149M 11.96M 11.71M 514M 385M 4.04M 3.53M 3.25M 3.03M 5.74M 5.83M 38.99M 15.16M 189M 15.17M 14.85M 652M
Net income 10.52M 110K 96.57K 88.75K 82.73K 157K 159K 1.07M 414K 5.17M 415K 406K 17.82M 21.47M 226K 197K 181K 169K 320K 325K 2.18M 846K 10.56M 847K 828K 36.37M
Net Debt -8.65M -90.9K -79.46K -73.03K -68.07K -129K -131K -877K -341K -4.25M -341K -334K -14.66M -38.73M -407K -356K -327K -305K -578K -587K -3.92M -1.53M -19.04M -1.53M -1.49M -65.6M
Logo Arvee Laboratories (India) Ltd.
Arvee Laboratories (India) Limited is an India-based company. The Company is engaged in manufacturing of specialized chemicals. It operates through Textile and Non-Textile segments. It offers polymer modifiers, contrast media intermediates, and drug intermediates. Its polumer modifier products include Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt, and 5-Sodiosulfo-Bis-Isophthalate. Its contrast media intermediate products include 5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Aminoisophthalate, 3,5-Dinitrobenzoic Acid, and 3,5-Diamino Benzoic Acid. Its drug intermediates include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine, and 2-Chloro-5-Nitrobenzoic Acid.
Employees
-
Date Price Change Volume
26-07-03 ₹164.96 +1.41% 2,328
26-07-02 ₹162.66 +0.06% 113
26-07-01 ₹162.56 -1.81% 2,157
26-06-30 ₹165.55 +0.49% 511
26-06-29 ₹164.75 -0.18% 7,510
  1. Stock Market
  2. Stocks
  3. ARVEE Stock